Triple-negative breast cancer (TNBC), a highly aggressive form of breast cancer is characterized by the absence of estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor-2 (HER2)2 as determined by immunohistochemistry3. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.